galantamine has been researched along with huprine x in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Badia, A; Camps, P; Clos, MV; Roman, S | 1 |
| Badia, A; Camps, P; Clos, MV; Muñoz-Torrero, D; Roman, S | 1 |
2 other study(ies) available for galantamine and huprine x
| Article | Year |
|---|---|
Potentiation effects of (+/-)huprine X, a new acetylcholinesterase inhibitor, on nicotinic receptors in rat cortical synaptosomes.
Topics: Acetylcholine; Aminoquinolines; Animals; Cerebral Cortex; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Galantamine; Heterocyclic Compounds, 4 or More Rings; Male; Mecamylamine; Nicotinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Synaptosomes | 2004 |
Nicotinic-receptor potentiator drugs, huprine X and galantamine, increase ACh release by blocking AChE activity but not acting on nicotinic receptors.
Topics: Acetylcholine; Alkaloids; Aminoquinolines; Animals; Atropine; Cholinesterase Inhibitors; Dopamine Antagonists; Dose-Response Relationship, Drug; Galantamine; Haloperidol; Heterocyclic Compounds, 4 or More Rings; In Vitro Techniques; Mecamylamine; Nicotinic Agonists; Nicotinic Antagonists; Parasympatholytics; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Nicotinic; Sesquiterpenes | 2005 |